DRUG EARNINGS RALLY IN THE THIRD QUARTER
DRUG EARNINGS RALLY IN THE THIRD QUARTER Major pharmaceutical firms see improvement in sales and earnings as the year progresses
DRUG EARNINGS RALLY IN THE THIRD QUARTER Major pharmaceutical firms see improvement in sales and earnings as the year progresses
It Lives for 29 Years? A lawsuit filed April 11 in the U.S. District Court in Los Angeles has grabbed
Big pharma plays hard ball with little biotech If you play with the big boys you might get hurt…
USDA Sued Over Drug-Growing Crops A coalition of environmental groups and consumer advocates sued the U.S. Agriculture Department in federal
Staffing needs seen in biotech industry A top Labor Department official said yesterday that community colleges nationwide could boost their
Getting Investors’ Pulses Beating Again Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004’s ‘promising products’
Getting Investors’ Pulses Beating Again Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004’s ‘promising products’
Financial Snapshot For October 2003 Stocks On New Plateau
Vatican steps in on biotech foods debate The Vatican stepped into the charged debate over genetically modified food on Monday,
A survey of strategic licensing practices in the pharmaceutical industry Alliances often appear to be a relatively cost-effective and rapid
A survey of strategic licensing practices in the pharmaceutical industry Read Post »